Last edition
News about Industrial talks
Anupam Rasayan signs Memorandum of Understanding (MoU) with 3xper Innoventure Limited, a technological collaboration for new age pharma molecules<br />
Industrial talks | 06/07/2023 | By Sudeep Soparkar | 779
Lupin recast may demerge API business for unlocking value
Lupin recast may demerge API business for unlocking value
Industrial talks | 27/06/2023 | By Sudeep Soparkar | 679
Dr. Reddy's enters the trade generics business in India
Dr. Reddy's enters the trade generics business in India
Industrial talks | 26/06/2023 | By Sudeep Soparkar | 341
Sanofi's Full Embrace of AI and Data Science to Accelerate Medical Breakthroughs for Patients
Sanofi “all in” on artificial intelligence and data science to speed breakthroughs for patients
Industrial talks | 15/06/2023 | By Sudeep Soparkar | 1592
IPA Set to Host 8th Global Pharmaceutical Quality Summit, Focusing on 'Patient Centricity - A New Manufacturing and Quality Paradigm
Industrial talks | 14/06/2023 | By Sudeep Soparkar | 962
Aurobindo Pharma completes plant installation in China
Aurobindo Pharma has completed the installation of its plant in China and is planning to commission it in the first quarter of next fiscal, said Santhanam Subramanian, Chief Financial Officer of the company.
Industrial talks | 07/06/2023 | By Sudeep Soparkar | 1177
PAG-led Sekhmet Pharmaventures announces hiring of Anil Khubchandani as MD and CEO
Accomplished industry executive to lead platform on next stage of growth
Industrial talks | 02/06/2023 | By Sudeep Soparkar | 975
Astellas Pharma to Transfer Manufacturing Plant, Business to Delpharm
Astellas Pharma announced that Astellas B.V., Astellas Pharma Europe B.V., and Astellas’ subsidiaries in the Netherlands have decided to sell and transfer the manufacturing plant located in Meppel to Delpharm Industries.
Industrial talks | 30/05/2023 | By Sudeep Soparkar | 760
IOL Chemicals and Pharmaceuticals bags CEP for Paracetamol to export in European market
The company started commercial production of the same in 2022 in its Punjab-based facility
Industrial talks | 09/05/2023 | By Sudeep Soparkar | 894
GSK in agreement to acquire late-stage biopharma company BELLUS Health
The acquisition provides GSK access to camlipixant, a potential best-in-class and highly selective P2X3 antagonist currently in phase III development for the first-line treatment of adult patients with RCC
Industrial talks | 25/04/2023 | By Sudeep Soparkar | 933
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy